The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

…, A Orazi, R Hasserjian, J Thiele… - Blood, The Journal …, 2016 - ashpublications.org
The World Health Organization (WHO) classification of tumors of the hematopoietic and
lymphoid tissues was last updated in 2008. Since then, there have been numerous advances in …

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

JW Vardiman, J Thiele, DA Arber… - Blood, The Journal …, 2009 - ashpublications.org
Recently the World Health Organization (WHO), in collaboration with the European Association
for Haematopathology and the Society for Hematopathology, published a revised and …

Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis

…, H Chang, F Hamm, P Elsner, JJ Thiele - International journal …, 2004 - Wiley Online Library
Melanoma and nonmelanoma skin cancers are among the most prevalent cancers in the
human population. Solar ultraviolet radiation is considered a major etiological factor but the …

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

…, RM Stone, MS Tallman, J Thiele… - Blood, The Journal …, 2022 - ashpublications.org
The classification of myeloid neoplasms and acute leukemias was last updated in 2016
within a collaboration between the World Health Organization (WHO), the Society for …

[BOOK][B] WHO classification of tumours of haematopoietic and lymphoid tissues

…, NL Harris, ES Jaffe, SA Pileri, H Stein, J Thiele… - 2008 - hero.epa.gov
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues is the second volume
of the 4th Edition of the WHO series on histological and genetic typing of human tumours…

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis …

A Tefferi, J Thiele, A Orazi… - Blood, The Journal …, 2007 - ashpublications.org
The Janus kinase 2 mutation, JAK2617V>F, is myeloid neoplasm-specific; its presence
excludes secondary polycythemia, thrombocytosis, or bone marrow fibrosis from other causes. …

High K/sub u/materials approach to 100 Gbits/in/sup 2

…, MF Toney, M Schwickert, JU Thiele… - IEEE Transactions …, 2000 - ieeexplore.ieee.org
High K/sub u/, uniaxial magnetocrystalline anisotropy, materials are generally attractive for
ultrahigh density magnetic recording applications as they allow smaller, thermally stable …

European consensus on grading bone marrow fibrosis and assessment of cellularity

J Thiele, HM Kvasnicka, F Facchetti, V Franco… - …, 2005 - haematologica.org
Quantification of characteristic bone marrow biopsy features includes basic parameters
such as cellularity and fiber content. These are important to assess the dynamics of disease …

[HTML][HTML] Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

…, DR Larson, L Müllauer, A Pardanani, J Thiele… - Leukemia, 2013 - nature.com
Under the auspices of an International Working Group, seven centers submitted diagnostic
and follow-up information on 1545 patients with World Health Organization-defined …

Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working …

G Barosi, RA Mesa, J Thiele, F Cervantes, PJ Campbell… - Leukemia, 2008 - nature.com
To exploit the diagnostic usefulness of the recently discovered JAK2 V617F mutation, as
well as the characteristic bone marrow histopathological features reported in BCR-ABL-…